Page 12 - PULSE@UM

research spotlight

RESEARCH SPOTLIGHT

THE ABC’S OF UROLOGICAL CANCER RESEARCH: (A = PROSTATE CANCER; B =
BLADDER CANCER; C = RENAL CELL CARCINOMA)

Professor Azad and Dr Jasmine attended and initiated the prostate cancer research collaboration with the
PRACTICAL consortium during its annual meeting in London, 2013.

PROFESSOR DR AZAD RAZACK and ethnic groups, leading to the different
PROFESSOR DR ONG TENG AIK pathophysiologies of the disease and treatment
DR JASMINE LIM outcomes. To date, the understanding of
DR RETNAGOWRI RAJANDRAM the development of cancerous cells remain
DEPARTMENT OF SURGERY
challenging, nevertheless, continuous effort
“The UM urology research unit enjoys a close is the key to unlock the unknown. With the
working relationship between urologists and passion of working on urological cancers,
scientists across nations. It has continued to here, in Faculty of Medicine (FOM), research
flourish and produce numerous human capitals into the “ABC” is in full swing. The researchers
over the past decades through both national are working from various aspects, looking into
and international collaborations, enabling basic the genetics of cancer patients, searching for
research findings to be translated into benefit for risk factors and genetic variants related to
patients and vice versa.” the increased risk of an individual to develop
urological cancer, particularly in a multi-
Uncontrollable growth of abnormal cell ethnic Asian population. The use of potential
potentially invades and spreads to other biomarkers obtained from the DNA databases
body parts in the form of cancer. Urological has greatly improved the risk prediction for
cancers can develop in organs such as the early detection that brings the prospect of
bladder, kidney, prostate and testicles. Similar a comprehensive DNA screening test and
to other cancers, it is often unpredictable and new treatments closer to reality, improving
can differ markedly across different racial treatment and patient care.

12